Global
Public-private partnerships (PPPs) are playing a pivotal role in strengthening Southeast Asia’s healthcare systems by expanding access, enhancing infrastructure, and fostering innovation amid growing demand and resource constraints.
The electronics industry is entering a new phase of rapid expansion. From consumer devices and electric vehicles to smart manufacturing systems, demand is growing for high-performance components that are smaller, lighter, and more reliable.
The Asia-Pacific (APAC) region, home to 60% of the global population, is emerging as a key market for global medical device companies. This shift is underscored by the potential of the APAC region, which encompasses a diverse array of cultures, languages, and socioeconomic backgrounds, and a healthcare market that has already surpassed Europe to become the second-largest market globally, right behind the United States.
The pharmaceutical industry stands as a pillar of global healthcare, dedicated to discovering, developing, manufacturing, and distributing medications that enhance and sustain human life. At the heart of these medications is the Active Pharmaceutical Ingredient (API) - the component responsible for delivering therapeutic benefits.
Thailand’s healthcare system is rapidly evolving, driven by the government’s Thailand 4.0 vision and the Ministry of Public Health’s Digital Health Strategy (2021–2025). Health technology (Healthtech) is now a key driver in enhancing patient care, hospital efficiency, and accessibility.
The proliferation of health tech innovations is accelerating exponentially. In 2023, the global digital health market was estimated at USD 240.9 billion and projected to grow at a compound annual growth (CAGR) of 21.9% from 2024 to 2030. This growth has been further accelerated by the COVID-19 pandemic, especially in evolving markets in Asia Pacific.
The Asia-Pacific region is at the forefront of the global business-to-business (B2B) eCommerce revolution, driven by rapid digital transformation and the increasing adoption of digital procurement solutions. The region’s eCommerce market is projected to grow at an impressive compound annual growth rate (CAGR) of 22.74% from 2023 to 2032, reaching USD 121 trillion in revenue.
Three-dimensional (3D) bioprinting is an additive manufacturing method that involves printing biomedical structures by deposition of viable cells, biological molecules, and biomaterials in a layer-by-layer fashion to create 3D structures like tissues and organs.
Global medical tourism has experienced significant growth in the past few decades. This is fueled by the increasing accessibility of affordable travel as well as improved access to high-quality care in emerging markets as they provide a more attractive choice than developed nations.
Singapore’s status as a leading medical tourism destination is threatened as international patients opt for cheaper alternatives. Rising medical costs and intensified competition from regional players like Thailand and Malaysia also drive foreign patients away from Singapore.
Southeast Asia stands at a pivotal moment in healthcare development. While the region represents 8.5% of the world’s population, it accounts for only 1.4% of global healthcare expenditure, a disparity that signals both challenges and unprecedented opportunities.
Thailand is experiencing a significant demographic shift. By 2031, over 20% of its population will be aged 65 or older, making it a super-aging society. This rapid shift presents challenges for the healthcare system but also opens doors for innovation and collaboration.
As we enter 2025, the skincare industry is undergoing a significant transformation driven by the global demand for sustainability. Consumers are increasingly seeking products that offer more than just promises of outer beauty; they are looking for transparency, ethical sourcing, and environmental responsibility.
In today’s laboratories, repetitive tasks and complex workflows often slow progress and place added strain on lab teams. Lab automation offers a practical solution, streamlining these tasks and transforming how labs operate.
In an era of heightened global uncertainty, supply chain leaders are under immense pressure to ensure the continuity and efficiency of their operations.
The Asia-Pacific dairy market is projected to grow at an annual rate of 4-5%, surpassing USD 243 billion by 2029. The growth will be primarily driven by drinking milk products, with a notable rise in the cheese segment.
Asia Pacific markets are increasingly dynamic centers of scientific, technological, and commercial innovation. As a result, the frequent launch of enterprising products across industry sectors is raising the expectations of customers and consumers.
As Vietnam's beauty and personal care market continues to evolve, DKSH serves as a strategic partner by leveraging its industry expertise to support local businesses. By providing high-quality ingredients, technical support, and valuable market insights, DKSH helps its partners stay ahead of trends and adapt to the changing demands of consumers.
How do you localize your approach in Asia’s complex and competitive consumer markets? Engaging shoppers requires a carefully tailored strategy for each market. Positioning products to convert local buyers into brand advocates must consider diverse economic, cultural, geographical, and behavioral contexts.
Alzheimer’s disease, and other forms of dementia, are progressive neurological disorders that lead to memory loss, cognitive decline, and the eventual inability to carry out simple tasks. Currently, more than 55 million people worldwide are living with dementia, with nearly 10 million new cases diagnosed each year with Alzheimer’s contributing up to 70% of these cases, as reported by the World Health Organization (WHO).
Ensuring patient safety in a rapidly evolving healthcare landscape is crucial as we shift focus from longevity to living healthier, more vital lives through technological innovation and personalized care.
Contact us to discover new opportunities.
Contact Us